Animal data onlyNot FDA approved

PEG-MGF side effects

Also known as: PEGylated mechano growth factor · Pegylated MGF · PEG MGF · Mechano growth factor pegylated

Updated Oct 24, 202620 sources

7 side effects reported for PEG-MGF: 2 from studies and labels, 5 from users and guides. 2 come with the ways people manage them.

PEG-MGF overview

Side effects reported in studies and labels

Rates as each trial or label states them. A rate from one trial does not carry over to research-grade vials or other doses.

From trials and regulators2

Clinical studies and regulatory documents.

Immune reaction to the product (immunogenicity)
Flagged by FDA as a possibly significant risk for some routes, along with peptide impurities. FDA found no human exposure data
Growth-promoting (proliferative) concern
Theoretical, from MGF expression in cancer biology in preclinical work. No human data either way

Side effects users and guides report

What people post and what dosing guides list. These are reports, not measured rates.

From users and guides5

Community reports, competitor and vendor guides, media.

Injection-site irritation
The most logged side effect among 25 PeptIQ app users (5 logs). One guide estimates 10 to 30% and says PEGylated peptides may irritate a little more
How people manage it
- Rotate sites between belly, thigh and upper arm, per guides.
Headache
Anecdotal; one guide puts it at 1 to 10% and notes it is not systematically documented
Nausea
Mild, anecdotal; one guide puts it at 1 to 10%
Anti-PEG antibodies
Theoretical; one guide rates it under 1%. Seen with approved PEGylated drugs, and could cut effect or cause hypersensitivity with repeat use
Low blood sugar
Theoretical; one guide rates it under 1% and likely lower than with IGF-1
How people manage it
- Guides suggest checking fasting glucose at baseline and at 4 weeks.

Who should avoid it, and what not to combine

Active cancer or a history of cancerCondition
Guides list it as a do-not-use because MGF signals cells to multiply.
Pregnancy and breastfeedingCondition
Never studied.
Past severe reaction to a PEGylated drugCondition
Anti-PEG antibodies may raise the risk of hypersensitivity.
InsulinSubstance
One guide flags a theoretical additive drop in blood sugar.

How much is known

Animal data only

No human study of PEG-MGF or plain MGF exists, and FDA found no human exposure data. The evidence is cell work on myoblasts, contested by a 2014 replication failure, plus mouse and sheep heart-injury studies of the MGF E-domain peptide, not PEG-MGF itself. Every dose on this page is a forum or guide convention.